EXPRES2ION BIOTECH HOLDING AB

Insiders ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 03/07/2024 BST			5-day change	1st Jan Change
1.2 ^SEK	+13.42%		+2.39%	-43.13%

05-16	ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ExpreS2ion Biotech Holding AB Announces Changes to Leadership Team	27/09/23	CI
ExpreS2ion Biotech Names Chief Scientific Officer	03/01/23	MT
ExpreS2ion Biotech Holding AB Appoints Dr. Farshad Guirakhoo as Chief Scientific Officer, Effective January 16, 2023	03/01/23	CI
ExpreS2ion Biotech Holding AB Announces Resignation of Allan Rosetzsky from the Board of Directors	06/10/22	CI
ExpreS2ion Biotech Holding AB Appoints Mattis F. Ranthe as New Chief Medical Officer, Effective February 1, 2022	21/12/21	CI
ExpreS2ion Biotech Holding AB Announces Board Changes	26/05/21	CI
ExpreS2ion Biotech Holding AB Announces Resignation of Gitte L. Pedersen from the Board of Directors	26/04/21	CI
ExpreS2ion Biotech Holding AB Announces Management Changes	11/01/21	CI
Expres2ion Biotech Holding AB Appoints Keith Alexander as New Chief Financial Officer, Effective October 1, 2020	18/08/20	CI
ExpreS2ion Biotechnologies Announces Change in Chief Executive Officer	20/12/19	CI
ExpreS2ion Biotech Holding AB Re-Appoints Mazars Set Revisionsbyrå AB as Auditor	23/05/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer